re: Ann: Arrowhead BID Updated Research Repor... In there report dated 16March they had share value @ .013-.0286
In this report even though we are suppose to be even closer to a manufacturer than an R&D co they rate MDV @ .006-.014 so all in all they have halved MDV's value.
Only three months difference in reports has the Share market in the medical/bio sector halved in the last 3 months?
Why the down grading in there projected pps. I will leave it to you good folks out there to read what they have to say and point out why the down grade. 50% downgrade.
Another great report for MDV
Ann: Arrowhead BID Updated Research Report Availa, page-3
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)